ArticleInternational journal of molecular medicine2016

miR-223 enhances the sensitivity of non-small cell lung cancer cells to erlotinib by targeting the insulin-like growth factor-1 receptor.

Feng-Yi Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.